C4 Therapeutics (CCCC) PT Lowered to $12 at Stifel
Tweet
Share
E-mailGet Alerts CCCC Hot Sheet
Price: $4.00 --0%
Rating Summary:
10 Buy, 5 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 5 | Down: 4 | New: 44
Rating Summary:
10 Buy, 5 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 5 | Down: 4 | New: 44
Join SI Premium – FREE
Stifel analyst Bradley Canino lowered the price target on C4 Therapeutics (NASDAQ: CCCC) to $12.00 (from $14.00) while maintaining a Buy rating.
You May Also Be Interested In
- DocMorris AG (DOCM:SW) PT Raised to CHF12.50 at Deutsche Bank
- Vonovia SE (VNA:DR) (VNNVF) PT Lowered to EUR29.50 at Goldman Sachs
- Barclays Downgrades Unite Group (UTG:LN) to Underweight
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
